Skip to content
Monday, May 16, 2022
HealthCare Africa Magazine

Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine

Africa Health & Wellness Expo ad
  • Home
  • TOPICS
    • INVESTMENTS & FUNDING
    • MERGERS & ACQUISITIONS
    • DISEASES UPDATES
    • HEALTHCARE DELIVERY
    • PHARMA MANUFACTURING
    • PEOPLE NEWS
    • CORONAVIRUS NEWS
    • REGULATORY & POLICY
  • THE MAGAZINE
    • About HealthCare Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • VIDEOS
  • COMPANY PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Lilly’s blockbuster diabetes drug wins FDA approval
  • Global Fund unveils strategy to reduce deaths from AIDS, TB, and malaria
  • FDA OKs BD's newest molecular diagnostics machine and its first test
  • FDA approves Medtronic's Onyx Frontier drug-eluting stent for treating CAD
  • Medtronic closes its deal on US$1.1B Intersect ENT acquisition
  • US NIH warrants Covid-19 technologies to WHO and MPP
  • First simulated patient treatment performed in Hospital-based BNCT Facility in Europe
  • Regulatory approvals delay CSL’s US$11.7 billion takeover of Vifor Pharma
  • Health and wellness startup FlexifyMe raises US$300K in seed round
  • Hologic secures FDA approval for Aptima CMV Quant assay, poised to challenge Abbott, Roche
You are here
  • Home
  • Merck

Tag: Merck

Africa Reproductive Care Society, Merck Foundation in pact to enhance fertility care

12 April 202212 April 2022

AFRICA – Africa Reproductive Care society (ARCS) has championed for fertility care and women’s healthcare capacity building in partnership with Merck Foundation. The Merck Foundation, the philanthropic arm of Merck…

Read More

US FDA approves Keytruda monotherapy for endometrial cancer

22 March 202222 March 2022

USA – According to a news release from, Merck, the Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab) for the treatment of patients with advanced endometrial carcinoma that is…

Read More

Merck details Keytruda’s post-surgery lung cancer win

18 March 202218 March 2022

USA – Merck has released specific data for Keytruda in early-stage lung cancer, indicating an advantage over Roche’s first-to-market Tecentriq. Postsurgery use of Keytruda reduced the risk of disease recurrence…

Read More

Merck’s bid to combine two top drugs for prostate cancer flops

16 March 202216 March 2022

USA – Merck & Co. has halted a Phase 3 trial testing a combination of two widely used cancer drugs, Keytruda and Lynparza, in patients with advanced prostate tumors due…

Read More

Pharma giants come together to draw up digital clinical measures for Alzheimer’s

15 March 202215 March 2022

USA –The Digital Medicine Society (DiMe) has announced a new collaboration involving Biogen, Eisai, Eli Lilly, and Merck & Co. to address a major barrier in determining whether potential treatments…

Read More

Lynparza approved in US as treatment for high-risk early breast cancer

14 March 202214 March 2022

USA – The FDA has expanded Lynparza (olaparib) approval by AstraZeneca and Merck & Co. to include adjuvant treatment of germline BRCA-mutated (gBRCAm) HER2-negative, high-risk, early breast cancer in patients…

Read More

Merck Animal Health receives FDA approval for two new antibiotics

4 March 20224 March 2022

USA – Merck Animal Health has received FDA approval for NUFLOR-S (florfenicol) Injectable Solution and AROVYN (tulathromycin injection) – broad-spectrum, prescription antibiotics that treat the most important organisms associated with…

Read More

WHO recommends antiviral drug for patients for Covid-19 treatment

3 March 20223 March 2022

SWITZERLAND –The World Health Organization has conditionally recommended the antiviral drug molnupiravir for patients with non-severe COVID-19 infection who are at high risk of hospitalization. The WHO Guideline Development Group…

Read More

Merck Foundation advocates for girls’ education to eradicate Female Genital Mutilation in Africa

7 February 20227 February 2022

AFRICA – Merck Foundation, the philanthropic arm of Merck KGaA Germany, champions for girls’ empowerment and education to eliminate Female Genital Mutilation (FGM) from African communities. The foundation aims to…

Read More

Private Equity firms mull co-bidding for Novartis generics arm

3 February 20223 February 2022

SWITZERLAND – Two private equity giants are discussing launching a joint bid for Novartis’ generics unit, Bloomberg has reported. Novartis announced last year that it was conducting a strategic review…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

Africa Health & Wellness Expo ad

Popular Posts Recent Posts

AAR Healthcare unveils new ultra-modern 140-bed capacity hospital

Ghanaian startup Yemaachi secures US$3M seed funding to advance cancer research

Lilly announces the Institute for Genetic Medicine and US$700 million investment

FDA OK’s Quantum’s Epione robot for liver cancer

Africa’s journey to healthcare independence, as fueled by effects of the ongoing pandemic

Lilly’s blockbuster diabetes drug wins FDA approval

Global Fund unveils strategy to reduce deaths from AIDS, TB, and malaria

FDA OKs BD’s newest molecular diagnostics machine and its first test

FDA approves Medtronic’s Onyx Frontier drug-eluting stent for treating CAD

Medtronic closes its deal on US$1.1B Intersect ENT acquisition

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Biogen Cancer China COVAX Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS India Investments & Funding Japan Johnson & Johnson Kenya Malaria Manufacturing Merck Mergers & Acquisitions Moderna MOH Kenya Nigeria Novartis Pfizer Pharmaceuticals Roche Sanofi Science & Technology South Africa Switzerland Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

HealthCare Africa MagazineFollow

Africa's No. 1 magazine that showcases the people, businesses and market trends in the pharmaceuticals, healthcare and biotech sectors in Africa & the World

HealthCare Africa Magazine
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

Health and wellness startup @FlexifyMe raises US$300K in seed round
https://t.co/vyCRnHxiil #healthtech #innovation #health #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment #wellness #startup

Reply on Twitter 1526125167860146177Retweet on Twitter 1526125167860146177Like on Twitter 1526125167860146177Twitter 1526125167860146177
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

Regulatory approvals delay @CSL’s US$11.7 billion takeover of @ViforPharma
https://t.co/evoEdIx4d2 #healthtech #innovation #healthcaredelivery #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment

Reply on Twitter 1526122199437934592Retweet on Twitter 1526122199437934592Like on Twitter 1526122199437934592Twitter 1526122199437934592
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

First simulated patient treatment performed in Hospital-based #BNCT Facility in #Europe
https://t.co/kMpazlYuAn #healthtech #innovation #health #science #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment @CosylabHQ

Reply on Twitter 1526121369926258688Retweet on Twitter 1526121369926258688Like on Twitter 1526121369926258688Twitter 1526121369926258688
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

The @NIH warrants Covid-19 technologies to @WHO and @MedsPatentPool
https://t.co/XZQvOsU2Cx #healthtech #innovation #healthcaredelivery #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment

Reply on Twitter 1526119119074082816Retweet on Twitter 1526119119074082816Like on Twitter 1526119119074082816Twitter 1526119119074082816
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 12, 2022

TPG Growth, @Temasek invest US$136 mln in @dragarwals_eye; @AdvAccountants exits
https://t.co/SfsSsS3rgp #healthtech #innovation #healthcaredelivery #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment

Reply on Twitter 1524666588082978816Retweet on Twitter 1524666588082978816Like on Twitter 1524666588082978816Twitter 1524666588082978816
Load More...

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa magazine

Food Business Africa magazine

Food Safety Africa magazine

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.